Scotiabank Maintains Sector Outperform on Amgen, Raises Price Target to $450

Benzinga · 1d ago
Scotiabank analyst Louise Chen maintains Amgen (NASDAQ:AMGN) with a Sector Outperform and raises the price target from $385 to $450.